Metraipolis › archive › dc_aeac669d4e77

Interstitial lung disease following combined CDK4/6 inhibitor therapy and radiotherapy in advanced breast cancer: a case report — Europe PMC PMID:41244784

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41244784
DOI: 10.3389/fmed.2025.1661867
License (as archived): solo-consultazione
Archived: 2026-11-08T21:55:59.716Z
SHA-256 of the archived text: 157c0b44bbff2d7b10fb2efedf61bd770c1c384ddc4df7682d634a8fb42869f5
Stable URL of this page: https://metraipolis.com/documento/dc_aeac669d4e77

How to cite

Interstitial lung disease following combined CDK4/6 inhibitor therapy and radiotherapy in advanced breast cancer: a case report — Europe PMC PMID:41244784 — Europe PMC (en), https://europepmc.org/article/MED/41244784 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aeac669d4e77 (Metraipolis archive dc_aeac669d4e77, sha256 157c0b44bbff2d7b10fb2efedf61bd770c1c384ddc4df7682d634a8fb42869f5)

BibTeX

@misc{dcaeac669d4e77,
  title = {Interstitial lung disease following combined CDK4/6 inhibitor therapy and radiotherapy in advanced breast cancer: a case report — Europe PMC PMID:41244784},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41244784},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aeac669d4e77; sha256 157c0b44bbff2d7b10fb2efedf61bd770c1c384ddc4df7682d634a8fb42869f5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41244784. Agents can read the archived copy with the MCP tool read_document.